Quantum Cyber (QUCY) Fundamentals 2026 — Revenue Analysis | SniperIQ
Quantum Cyber (QUCY) is a DE-listed Healthcare company in Medical - Diagnostics & Research with a market capitalization of
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Quantum Cyber's market cap?
Quantum Cyber (QUCY) has a market capitalization of approximately
What is Quantum Cyber's P/E ratio?
Quantum Cyber's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Quantum Cyber?
Quantum Cyber runs a net profit margin of -2937.8%, a gross margin of 100.0%, and an operating margin of -2723.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Quantum Cyber generate?
Quantum Cyber reported revenue of $537,080 for fiscal year 2025, with net income of -
Does Quantum Cyber pay a dividend?
Quantum Cyber does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Quantum Cyber financially healthy?
Quantum Cyber carries a debt-to-equity ratio of 0.03x and a current ratio of 2.11x, with a market beta of 2.29. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Quantum Cyber a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Quantum Cyber (QUCY) the key facts are: market cap
Track Quantum Cyber's full fundamentals live
Get Quantum Cyber's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.